EVALUATION OF SOME SEROLOGICAL MARKERS IN TESTING THE PROGRESSION OF HEPATIC FIBROSIS IN CHRONIC HCV PATIENTS
Assmaa Hanafy Mahmoud;
Abstract
The rapid advances in understanding the pathophysiology of liver fibrosis have generated intense interest in exploiting these insights to develop anti-fibrotic therapies for patients with chronic liver diseases. While no agents are yet approved for this i
Other data
| Title | EVALUATION OF SOME SEROLOGICAL MARKERS IN TESTING THE PROGRESSION OF HEPATIC FIBROSIS IN CHRONIC HCV PATIENTS | Other Titles | تقييم بعض الدلالات المصلية لإختبار تقدم التليف الكبدى فى مرضى الإلتهاب الكبدى الوبائى(ج) المزمن | Authors | Assmaa Hanafy Mahmoud | Keywords | EVALUATION OF SOME SEROLOGICAL MARKERS IN TESTING THE PROGRESSION OF HEPATIC FIBROSIS IN CHRONIC HCV PATIENTS | Issue Date | 2011 | Description | The rapid advances in understanding the pathophysiology of liver fibrosis have generated intense interest in exploiting these insights to develop anti-fibrotic therapies for patients with chronic liver diseases. While no agents are yet approved for this i |
Attached Files
| File | Size | Format | |
|---|---|---|---|
| 103550p3051.pdf | 146.3 kB | Adobe PDF | View/Open |
Similar Items from Core Recommender Database
Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.